• Criptomoedas
  • Mercados de Previsão
  • Notícias
  • Trading Agêntico
  • Artigos
  • Ligas

Pesquisar Criptomoedas

Criptomoedas em tendência

CoinRithm

Empresa

Entidade legal
Bees-x Limited
Número da empresa
13308136
Constituída em
England and Wales
Sede registrada
Monmouth House, High Street, Watford, England, WD17 1LN

CoinRithm é um serviço de informação e pesquisa operado pela Bees-x Limited. Não é autorizado pela Financial Conduct Authority (FCA) a realizar atividades reguladas, e nada neste site constitui aconselhamento financeiro.

Explorar

CriptomoedasMercados de PrevisãoNotíciasArtigosAgent ArenaLigas

Recursos

Painel de ControleComércio SimuladoTrading AgênticoCarteiraLista de ObservaçãoConfigurações

Empresa

Sobre NósMetodologiaTermos de UsoPolítica de PrivacidadePolítica de CookiesAviso Legal

Suporte

Apoio ao ClienteFAQKit para desenvolvedoresDocumentação MCP

Redes Sociais

X (Twitter)FacebookLinkedInTelegramInstagramTikTokYouTube
© 2026 CoinRithm. Direitos reservados.
Disponível no Google PlayBaixar na App Store
  • Início
  • MercadosMercados de Previsão
  • Notícias
  • Painel de Controle
  1. Mercados de Previsão
  2. Health & Medicine
  3. When will Compass Pathways submit a NDA for COMP360 psilocybin?
When will Compass Pathways submit a NDA for COMP360 psilocybin?

When will Compass Pathways submit a NDA for COMP360 psilocybin?

1.0% (24h)Health & MedicineOne-OffCiênciaBusiness & Corporate2m
KalshiKalshiVerificar disponibilidadeKYC obrigatório2% de taxa
Probabilidade implícita atual
before September
before September 31%+1.0%
Líder entre 6 opções
Qualidade do mercado

28 / 100

Baixa qualidade
Volume 24h

0,3 €

Liquidez

38,2 €

Baixa liquidez
Compra / Venda

22.0% / 31.0%

Spread

40.9%

Spread amplo
Dados do mercado

Atualizado há 3 minutos

24/03/26, 14:001/09/26, 14:00

Tendências

Resultado24hProbabilidade

Resultado escolhido

before September31%

Regras

If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.

Kalshi
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Oct 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Nov 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Dec 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Jan 1, 2027, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.

Mercados Relacionados

When will Beam Therapeutics submit a BLA for Risto-cel?

When will Beam Therapeutics submit a BLA for Risto-cel?

0,3 €
before April 2027: 72%KalshiKALSHI
Will there be a year without polio before 2030?

Will there be a year without polio before 2030?

0 €
Sim: 10%KalshiKALSHI
When will Intellia Therapeutics submit a BLA for Lonvo-z?

When will Intellia Therapeutics submit a BLA for Lonvo-z?

0 €
before September: 45%KalshiKALSHI
Which countries will have an Ebola case in 2026?

Which countries will have an Ebola case in 2026?

108,8 €
Uganda: 100%PolymarketPOLYMARKET
US fertility rate up in Q1 2026?

US fertility rate up in Q1 2026?

0 €
Sim: 36%PolymarketPOLYMARKET
Which geographical areas will Tomorrow Bio cover at the end of 2026?

Which geographical areas will Tomorrow Bio cover at the end of 2026?

1,1 mil €
🇨🇦 Canada: 23.9%Manifold MarketsMANIFOLD MARKETS

Ativos nestes tópicos

BitcoinBTC$62,682.54+2.38%EthereumETH$1,651.16+1.73%SolanaSOL$65.16+1.80%DogecoinDOGE$0.0851+1.95%XRPXRP$1.12+0.49%BNBBNB$595.34+1.77%

Notícias Relacionadas

JPMorgan plans longer-running AI agents for corporate workflows Crypto NewsA16z, Paradigm lead $175 million bet to move global credit markets onchainCoindeskMorpho raises $175M at $2B valuation for institutional DeFi pushCrypto NewsAmazon signs Corning fiber deal to expand U.S. data centersCrypto NewsSpaceX Price Prediction: Will IPO Hype Justify a Multi-Trillion Dollar Valuation?Blockchain ReporterA massive hiring wave reveals trading firms are no longer viewing Polymarket as a niche betting toolCoindesk

Regras

If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.

Kalshi
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Oct 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Nov 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Dec 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Jan 1, 2027, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.